3rd World Congress on
Cancer Science & Therapy
October 21-23, 2013 San Francisco, USA
Home ABOUT OPEN ACCESS CONFERENCES JOURNALS FAQs BLOG CONTACT
Cancer Science-2013
Home
Gallery
Cancer Science-2013 Report

The 3rd World Congress on Cancer Science & Therapy was organized by OMICS Group Inc., during October 21-23, 2013 at Double Tree by Hilton Hotel San Francisco Airport, USA. Active participation and generous response was received from the Organizing Committee Members, Editorial Board Members of OMICS Group Journals, scientists, researchers, as well as experts in the cancer research, Non-government organizations, and students from diverse groups who made this conference as one of the most successful and productive events in 2013 from OMICS Group.

The conference was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who have driven this event into the path of success.

The conference was initiated with a warm welcome note from Honorable guests. The proceedings went through interactive sessions and panel discussions headed by Jimmy T. Efird, Brody School of Medicine, USA; honorable Moderator for the conference.

The conference proceedings were carried out through various Keynote-presentations by:

  • Dr. Stewart Sell, Wadsworth Center, USA
  • Dr. Michael Retsky, Harvard School of Public Health, USA
  • Dr. Jimmy T. Efird, Brody School of Medicine, USA
  • Dr. Sudhakar Akul Yakkanti, SRI International, USA
  • Dr. Sherry A. Bradford, Buffalo School of Medical and Biomedical Sciences, USA

Also, the conference proceeding was encouraged through the wonderful workshop session on “ Animal Models of Cancer Therapy” organized by Dr. Dorothee Herlyn, The Wistar Institute, USA

OMICS Group has taken the privilege of felicitating Cancer Science-2013 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event. OMICS Group, on behalf of the conference exhibitors congratulates the Best Poster awardees for their outstanding performance in the field of Cancer Science & Therapy and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Cancer Science-2013. We are glad to inform that all accepted abstracts for the conference have been indexed in OMICS Group Journal of Cancer Science & Therapy and Journal of Carcinogenesis & Mutagenesis as a special issue. Basing on the conference theme, "Innovations and Novel Therapeutic Strategies in Cancer Science speakers recommended organizing the conference in the field of Cancer Science and Therapy also in the next year.

We are also obliged to various experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance towards the success of Cancer Science-2013. With the unique feedback from the conference, OMICS Group would like to announce the commencement of the "4th World Congress on Cancer Science & Therapy" to be held during October 20-22, 2014 at Chicago, USA.

 



Expert Presentations
Stewart Sell

Wadsworth Center

USA
Michael Retsky

Harvard School of Public Health

USA
Jimmy T. Efird

Brody School of Medicine

USA
Su-Shing Chen

University of Florida

USA
Sudhakar Akul Yakkanti

Cell Signaling Laboratory, SRI International

USA
Sherry A. Bradford

AccuTheranostics, Inc.,

USA
Dorothee Herlyn

The Wistar Institute

USA
Kun Ping Lu

Harvard Medical School

USA
Porunelloor A. Mathew

University of North Texas Health Science Center

USA
Thomas Kieber-Emmons

University of Arkansas for Medical Sciences

USA
Karli Rosner

Wayne State University

USA
David A. Fenstermacher

Virginia Commonwealth University

USA
Miral Dizdaroglu

National Institute of Standards and Technology

USA
Panikar Wadhera

Brooklyn hospital center

USA
Martin McMahon

University of California

USA
Clemens Krepler

The Wistar Institute

USA
Shiaw-Yih (Phoebus) Lin

MD Anderson Cancer Center

USA
Alexandru Almasan

Cleveland Clinic Foundation

USA
Jac A. Nickoloff

Colorado State University

USA
Biana Godin

Houston Methodist Research Institute

USA
John Rothman

Update Pharma Inc.

USA
Stephen J. Beebe

Old Dominion University

USA
Sandip K. Mishra

Institute of Life Science

India
Alvaro Macieira-Coelho

French National Institute of Health

France
Reza Hakkak

University of Arkansas for Medical Sciences

USA
King-Thom Chung

The University of Memphis

USA
Sergey N. Rumyantsev

Andent, Inc.

USA
Johann Wanek

University College London

UK
Fruhmann Johanna

Medical University Hospital Graz

Europe
Joachim Greilberger

Medical University of Graz

Austria
Nicola Cirillo

The University of Melbourne

Australia
Judy Wilyman

University of Wollongong

Australia
Karen McGuire

The Apatone Development Center

USA
Renat R. Letfullin

Rose-Hulman Institute of Technology

USA
Roland B. Sennerstam

Karolinska Hospital

Sweden
Michela Zanardi

ASLTO2 SAN Giovanni Bosco Hospital

Italy
Ashrafi G. Hossein

Kingston University

UK
Xiaowei Xu

University of Pennsylvania

USA
Kinfe Ken Redda

Florida A&M University,

USA
Michael J. Powell

DiaCarta, Inc.

USA
Laleh Alisaraie

Memorial University of Newfoundland

Canada
Wei Wang

Anhui Provincial Hospital

China
Anupam Bishayee

American University of Health Sciences

USA
Peng Lee

New York University Langone Medical Center

USA
Harten

SK Queensland Institute of Medical Research

Australia
Angus Harding

The Diamantina Institute

Australia
Jozef Oleksyszyn

Wroclaw University of Technology

Poland
Giorgia Urbinati

Institut Gustave Roussy

France
Francesco Merolla

University Federico II of Naples

Italy
Gregory Lee

University of British Columbia

Canada
Ana Ramirez de Molina

IMDEA Food Institute

Spain
Conference Secretariat: Cancer Science-2013, Conference Series Conferences
5716 Corsa Ave, Suite 110, Westlake, Los Angeles, CA 91362-7354, USA
Tel: +1-650-268-9744, Fax: +1-650-618-1414
Toll free: 1-800-216-6499(USA & Canada),
1-800-651-097(Australia), 0805-080048(Europe)
Operated by: Editors - Journal of Cancer Science & Therapy, Journal of Carcinogenesis & Mutagenesis and Journal of Chemotherapy
The Organizers reserve the rights to make changes and adjustment to the information in this website
Copyright 2008-2012 Conference Series - All rights reserved